| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch.
Adverse events reported to FDA Adverse Event Reporting System for long-acting injectable buprenorphine during the first 18 months postlaunch.
Dawson BJ, Frost MP, Budilovsky-Kelley NR, Fiore GJ, Friedman A, Kaempfer C, Cohen JM.
J Subst Use Addict Treat. 2026 Aug 25;191:210095. doi: 10.1016/j.josat.2026.210095. Epub ahead of print. PMID: 42641796.
https://www.jsatjournal.com/article/S2949-8759(26)00215-8/fulltext